HCB101
Gastric Cancer (HER2+), HNSCC, CRC, TNBC, SCLC
Phase 1b/2aActive
Key Facts
Indication
Gastric Cancer (HER2+), HNSCC, CRC, TNBC, SCLC
Phase
Phase 1b/2a
Status
Active
Company
About HanchorBio
A clinical-stage biotech using its FBDB™ platform to develop multi-specific fusion proteins targeting immune checkpoints for oncology and autoimmune diseases.
View full company profile